A large number of clinical trials have shown stem cell therapy to be a promising therapeutic
approach for the treatment of cardiovascular diseases. Since the first transplantation into …

COVID-19 has claimed millions of lives during the last 3 years since initial cases were
reported in Wuhan, China, in 2019. Patients with COVID-19 suffer from severe pneumonia …

Anthracycline cardiotoxicity remains a serious problem in paediatric and adult cancer
survivors, and the advancement of cardio-oncology is a necessary step for an effective care …

After acute myocardial infarction, ventricular remodeling is characterized by changes at the
molecular, structural, geometrical and functional level that determine progression to heart …

The cardiotoxicity of doxorubicin is becoming an interdisciplinary point of interest given a
growing population of cancer survivors. The complex and not completely understood …

Background: Stem cell–based therapy has emerged as a potential therapy in acute
myocardial infarction (AMI). Although various approaches have been studied, intracoronary …

Previous studies suggest that diabetes impairs hematopoietic stem cell (HSC) mobilization
in response to granulocyte colony-stimulating factor (G-CSF). In this study, we tested …

After two decades of intensive research and attempts of clinical translation, stem cell based
therapies for cardiac diseases are not getting closer to clinical success. This review tries to …

Ischemic heart disease, which is one of the top killers worldwide, encompasses a series of
heart problems stemming from a compromised coronary blood supply to the myocardium …

Acute myocardial infarction (AMI) triggers mobilization of bone marrow (BM)-derived
stem/progenitor cells (BMSPCs) through poorly understood processes. Recently, we …